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Abstract
Background
Tuberculosis (TB) has overtaken HIV as the biggest infectious disease killer, with the major-
ity of deaths occurring in sub-Saharan Africa. However it is unknown how differences in bac-
terial load alter host immune profiles in the sputum and blood of TB patients.
Methods
16S ribosomal RNA analysis was used to determine bacterial load in sputum samples
obtained from 173 patients with active TB (57 pre-treatment and 116 post-treatment). Host
analyte concentrations in sputum and Mycobacterium tuberculosis (Mtb) antigen stimulated
whole blood assay supernatants were analysed using multiplex cytokine arrays.
Results
Multiple logistic regression adjusting for age, sex and HIV status showed highly significant
correlation of bacterial load with IL1β, IL2, IL1RA, IL4, IL6, IL8, IL9, IL15, IL17, EOTAX,
FGF, IFN-γ, GCSF, MCP1, M1P1α, M1P1β, PDGF, TNFα, VEGF in sputum. With increas-
ing time on treatment, FGF levels in sputum displayed the most significant inverse correla-
tion with reduction in bacterial load.
Conclusions
We show that differences in bacterial load correlates with changes in several host biomark-
ers. These findings have implications for development of tests for TB diagnosis and treat-
ment response.
Introduction
Despite recent efforts, tuberculosis (TB) persists as a global health problem with an estimated
10.4 million new cases and 1.8 million deaths in 2015 [1]. TB is caused by inhalation of
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Mycobacterium tuberculosis (Mtb), a gram positive, acid-fast bacillus (AFB) [2]. Two major
roadblocks in combating TB are the limitations of current diagnostic tests and difficulties in
assessing the early treatment response. We hypothesise this is due in part to the large variabil-
ity in Mtb bacterial load in individual patients.
The molecular bacterial load (MBL) assay amplifies the 16S ribosomal RNA of Mtb, which
degrades much faster than DNA and therefore indicates the level of viable bacteria. It allows
the fast and accurate quantification of bacterial burden and allows monitoring of patient
response within the first three days of treatment [3].
Patients with multiple respiratory symptoms are likely to have higher bacterial loads, which
are associated with poorer prognosis [4] and more extensive transmission of active TB [5].
Additionally, it has been shown that patients with higher colony forming units (CFUs) in their
sputum are more likely to have cavitary disease [6]. Thus, determining the bacterial load
would be beneficial for optimal patient management.
The identification of surrogate markers for bacterial load may help to predict treatment
outcome, treatment response and risk of reactivation of TB similar to the use of viral load/
CD4 count for determining disease severity and response to anti-retroviral therapy in HIV
infected subjects [7]. Changes in host immune profiles in relation to bacterial load have been
crudely studied previously using smear grade including differences in antibody profiles [8]
and polyfunctional T cell profiles [9]. However, correlation of host markers with specific,
quantifiable bacterial loads has not been performed to date.
We have previously shown that ex vivo host factors in sputum can accurately distinguish
between TB and other respiratory diseases (ORD) [10] with levels significantly reducing as
early as 2 weeks post treatment initiation (Sutherland et al, unpublished). Thus we hypothe-
sised that these surrogate markers in sputum could be used to distinguish different bacterial
levels at diagnosis and for treatment monitoring.
The aim of this study was to determine how differences in quantifiable bacterial load relate
to differences in host immune profiles in sputum and blood before and after treatment initia-
tion. Since higher bacterial burden has been shown to be an important risk factor for treatment
failure and relapse, our findings have implications for patient management including diagno-
sis, prognosis and treatment monitoring.
Methods
Ethics statement
This work was approved by the MRC/Gambian government joint ethics committee. Written
informed consent was provided by all study participants.
Subjects and samples
173 HIV negative adult patients with smear-positive TB were recruited. Sputum was collected,
digested using Sputolysin (Merck, USA) and centrifuged at 1500rpm. The supernatant was
removed and stored for host cytokine/chemokine analysis at -20˚C and the bacterial pellet was
resuspended in Trizol (ThermoFisher Scientific, USA) and stored at -80˚C until analysis. All
samples were analysed by AFB-smear microscopy and GeneXpert MTB-RIF. Heparinised
blood was collected from 86 subjects and stimulated overnight with Mtb antigens.
Preparation of Mtb Standards for the MBL Assay
Five hundred microliters of wild-type Mtb (H37Rv) stock and 800μl of mycobacteria growth
indicator tube (MGIT) growth supplement were added to a MGIT tube (Becton Dickinson,
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USA) and incubated in a BACTEC MGIT 960 (Becton Dickinson, USA) machine for five days.
Viability was confirmed via a fluorescent reaction in the MGIT tube. The tube was then mixed
by hand, and 500μl was inoculated into 20μl 7H9-Tween-20 and incubated at 37˚C. Optical
density (OD) was measured using a spectrophotometer every 2 days to assess the growth of the
bacteria in conjunction with the McFarland scale. Once an OD of 2.2 was reached 1ml aliquots
of the suspension were frozen at -80˚C in Trizol. To confirm the top standard concentration,
10-fold serial dilutions of 10−1 to 10−5 were performed with 7H9 media on one aliquot. Three
20 μl drops were plated onto 7H11 agar and incubated at 37˚C for three weeks and colony
forming units (CFU) were counted.
Extraction of RNA
Before extraction, 2 μl of 560 RNA Internal Control RNA (Bioline, UK) was spiked into 1ml
sputum samples in Trizol. Two hundred microliters of chloroform was then added to each
tube, samples were mixed vigorously and incubated at room temperature (RT) for 10 min.
Samples were then centrifuged at 13,000 rpm for 15 mins and the upper aqueous phase was
transferred to fresh tubes. An equal volume of 70% ethanol (approx. 600 μl) was added to each
tube and mixed vigorously. The sample solutions were then transferred to RNeasy MiniElute
Spin Columns (Qiagen, Netherlands) and RNA purified according to Qiagen protocol. For the
standards, RNA was extracted and ten-fold serial dilutions performed using nuclease free
water (Qiagen, The Netherlands).
Molecular Bacterial Load Assay
Levels of 16S RNA and internal control (IC) were quantified using reverse transcription poly-
merase chain reaction (RT-PCR). To detect 16S RNA, a master mix containing 12.5 μl Quanti-
tect Master Mix, 6.65 μl of nuclease free water, 0.25 μl reverse transcriptase, 0.3 μl of 16S-ROX
(Rox-AGGACCACGGGATGCATGTCTTGT-BHQ2) (all supplied by Qiagen, Netherlands)
per reaction was prepared. A master mix containing 12.5 μl Quantitect Master Mix, 5.05 μl of
nuclease free water, 0.25 μl reverse transcriptase, 1.2 μl 50nM MgCl2+ (Qiagen, The Nether-
lands) and 1 μl VIC labelled 560 Control Mix (Bioline, UK) per reaction was prepared to detect
the IC. 5μl of RNA standards, samples or H20 were added to the 96 well plate in triplicates;
20 μl of 16S-ROX mastermix was added to two wells, 20 μl of IC mastermix was added to the
third. The plate was briefly vortexed, then centrifuged at 10,000 rpm for 30s before being
placed in 7500 Real-Time PCR System (Applied Biosystems, USA). The cycling parameters
were set to 50˚C for 30 mins, 95˚C for 10 mins, then 45 cycles of 95˚C for 15 secs and 60˚C for
1 min. Analysis was performed on ABI 7500 software (version 2.3, Affymetrix, USA).
Multiplex Cytokine Arrays
Sputum and Mtb-stimulated whole blood assay (WBA) supernatants were analysed using Bio-
Plex Pro Human 27-Plex Kits (Bio-Rad, Belgium). 450ul of heparinised whole blood was stim-
ulated with Purified protein derivative (PPD; SSI, Denmark) or ESAT-6 and CFP-10 (EC;
kindly provided by Prof. Tom Ottenhoff, LUMC, The Netherlands; both at final concentration
of 10μg/ml). Unstimulated (NIL) whole blood was used to determine background cytokine
levels. Assays were conducted as previously described [10]. Analytes included IL-1β, IL-1ra,
IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL12p70, IL-13, IL-15, IL-17A, eotaxin, FGF
Basic, G-CSF, GM-CSF, IFN-γ, IP-1O, MCP-1, MIP-1α, MIP-1β, PDGF-BB, RANTES, TNF-α
and VEGF. Plates were read using a Magpix Multiplex Reader (BioRad, Belgium). Background
values from the unstimulated wells were subtracted from EC and PPD values.
Host Correlates of Bacterial Load in TB
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Statistics
Spearman’s rank correlation was used to compare 16S RNA measurements with other mea-
surements of bacterial load (smear microscopy, CXR, GeneXpert). A Mann-Whitney U test
was used to compare pre and post-treatment MBL results. A Spearman’s Rank correlation
matrix was used to determine if a correlation existed between mean bacterial load and cytokine
profiles in sputum and WBA supernatants. From the associations observed a multiple logistic
regression model was used to adjust for time on treatment, age, sputum smear grade, HIV sta-
tus, gender and CXR severity. Statistical analyses were performed with Stata v. 14 (StataCorp,
USA) or GraphPad Prism v.6.0 (Software MacKiev, USA). Adjustment for multiple compari-
sons was performed using a False Discovery Rate with p-values0.035 considered significant.
Results
Patient demographics
Of 173 patients analysed, 24% were female and 75% male (Table 1) with a median[interquartile
range (IQR)] age of 32.7[25.1–40.3] years. 80.3% of subjects were HIV negative with 4.6% con-
firmed positive and 15% unknown. The majority of subjects had sputum smear grade of 3+
(44.5%) and CXR score of 2 (moderate infiltration; 55.5%) (Table 1).
Quantifying bacterial load in sputum using the MBL assay
The mean Cycle threshold (Ct) value was determined from duplicate wells (the average CV for
all samples was 2.1%) and construction of a standard curve allowed us to quantify the bacterial
Table 1. Patient demographics.
Characteristic n(%)
Sex
Female 42 (24.3)
Male 129 (74.6)
Missing 2 (1.2)
Chest X-ray
Zero 1 (0.6)
One 35 (20.2)
Two 96 (55.5)
Three 11 (6.4)
Missing 30 (17.3)
HIV status
Negative 139 (80.3)
Positive 8 (4.6)
Missing 26 (15)
Sputum smear grade
Zero 8 (4.6)
One Plus 33 (19.1)
Two Plus 53 (30.6)
Three Plus 77 (44.5)
Missing 2 (1.2)
Age (Mean (SD)) 32.7 (12.2)
Days on tx (Mean (SD)) 12.6 (20.2)
HIV, Human Immunodeficiency Virus; SD, standard deviation; tx, treatment
doi:10.1371/journal.pone.0168272.t001
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load. The upper and lower limits of detection using serially diluted standards were 108 and 102
cfu/ml respectively (Fig 1). Samples that were reported ‘undetermined’ by the software were
assigned a Ct of 40 and a corresponding bacterial load of 100 cfu/ml for the purpose of statisti-
cal analysis. No influence of mycobacterial strain was observed on MBL assay results similar to
our previous findings with GeneXpert [13]. The Ct values from the MBL assay and GeneXpert
probe B showed strong correlation (r2 = 0.76, p = 0.0002; Fig 1B) at recruitment.
Changes in Bacterial Load Pre- and Post-treatment
The MBL assay was used to compare the bacterial loads of patient’s pre- and post-treatment
initiation using Wilcoxon matched pairs analysis. The median bacterial load of patients pre-
treatment was significantly higher than following treatment initiation (median [IQR] = 88107
[19169–652533] copies pre-tx compared to 0[0–0] copies post-tx; p<0.0001; Fig 2). By 6
months, all subjects had 0 viable bacilli present in their sputum.
Correlation of bacterial loads and host cytokine profiles
A Spearman’s Rank correlation matrix was created to determine if there were significant corre-
lations between bacterial load and cytokine profiles of WBA and sputum supernatants (Fig 3).
There was no correlation with bacterial load at recruitment with the level of any cytokine from
unstimulated (NIL) or EC stimulated whole blood. However there was a statistically significant
inverse correlation between bacterial load and RANTES levels following PPD stimulation (r2 =
-0.3, p = 0.0084). In digested sputum samples, the bacterial load correlated strongly (r>0.4)
with levels of IL-1β (p< 0.0001), IL-2 (p<0.0001), IL-8 (p<0.0001), IL-17a (p<0.0001), Eotaxin
(p<0.0001), FGF (p<0.0001), IFN-γ (p<0.0001), MIP-1α (p<0.0001), PDGF (p<0.0001),
TNFα (p<0.0001) and VEGF (p<0.0001) (Fig 3). Bacterial load also correlated weakly (r<0.4)
but significantly with IL-1ra (p = 0.0058), IL-4 (p<0.0001), IL-6 (p = 0.0049), IL-13 (p =
0.0024), IL-15 (p<0.0001), G-CSF (p = 0.0016), MCP-1 (p = 0.0005), MIP-1β (p<0.0001) and
RANTES (p = 0.0001) (Fig 3).
When sputum analytes were correlated with days on TB therapy we found a significant
inverse correlation with levels of IL1β, IL2, IL4, IL8, IL15, IL17, Eotaxin, FGF, IFN-γ, MIP-1α,
MIP-1β and TNF-α (Fig 4B). The strongest inverse correlation was with FGF (r = -0.3234; Fig
3). Following multiple logistic regression adjusting for time on therapy, age, sex, HIV status,
smear grade and CXR score, we found a significant correlation between bacterial load and lev-
els of IL1β, IL2, IL4, IL8, IL17, Eotaxin, FGF, IFN-γ, MIP1α, MIP1β, PDGF and TNFα (all
p<0.0001).
Comparison of cytokine profiles in patients with high and low bacterial
loads
The samples were then grouped into high and low bacterial load, depending on whether they
were above or below the median (48059 copies/ml) bacterial load respectively. There were no
differences in any analyte following EC and PPD stimulation (data not shown). However, the
majority of analytes showed significant differences in the ex vivo samples (unstimulated blood
and sputum). Median levels of IL-15, MIP-1α and TNF-α both increased significantly in NIL
and sputum samples in subjects with high versus low bacterial load (Fig 4). Conversely, IL-2,
IL4, IL6, IL9, IL13, IL17, Eotaxin, IFN-γ, MCP-1, MIP-1b, PDGF, RANTES and VEGF all
decreased significantly in NIL but increased significantly in sputum samples with high bacte-
rial load (Fig 4). Additionally, IL1ra, IL8, FGF and GCSF all increased significantly in sputum
but showed no difference in NIL samples in subjects with high versus low bacterial load while
IL4, IL10, GMCSF and IP10 all showed differences in NIL but not sputum samples (Fig 4).
Host Correlates of Bacterial Load in TB
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Discussion
The aim of this study was to determine changes in Mtb load in patients before and after initia-
tion of TB therapy using 16S rRNA analysis and correlate this with host immune biomarkers in
sputum and blood. We were able to show a significant correlation of quantifiable, viable bacte-
rial load with multiple host factors in sputum and unstimulated whole blood.
Bacterial load determined using 16S RNA analysis showed a highly significant correlation
with GeneXpert MTB-RIF Ct values before treatment initiation. However, the MBL assay has
two major advantages over the GeneXpert: firstly it will only detect viable bacteria and can
therefore be used to monitor treatment response and secondly, it can provide quantitative
analysis of bacterial load, which allows for more accurate diagnosis and treatment monitoring.
In addition, we have shown MBL to correlate with host biosignatures before and after treat-
ment initiation, which could be used for generation of surrogate markers of disease severity
and treatment response.
A significant decline in bacterial load was found as early as 1 week after treatment initiation.
Furthermore, we were able to show a significant inverse correlation with time on treatment
and the level of several host factors in the same sputum sample used for the MBL assay. This
included IFN-γ, TNF-α, IL2, IL4, IL15, IL17, IL1β, MIP1α/β, FGF and Eotaxin suggesting a
general reduction in the pro-inflammatory response. The most highly correlated analyte with
Fig 1. Correlation of bacterial load with cycle threshold values. RT-PCR was performed in duplicate on
RNA extracted from sputum samples of TB patients. A: Log10 bacterial load versus Ct values of Mtb present
in sputum pellets. B: Correlation of Ct values from GeneXpert and 16S RNA analysis. Data were analysed
using Spearman rank correlation.
doi:10.1371/journal.pone.0168272.g001
Fig 2. Mtb bacterial load pre- and post-treatment initiation. Sputum samples from patients pre and post
treatment (n = 27) were analysed using the MBL assay. Line indicates median. Data were analysed using Wilcoxon
matched pairs test.
doi:10.1371/journal.pone.0168272.g002
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treatment response was FGF, which we have previously shown to accurately distinguish
between TB and other respiratory diseases (ORD) in sputum samples [10].
Many studies have assessed the difference between immune profiles of latent and active TB
disease [ie 11], and the changes in cytokines during bacterial clearance (determined by smear
microscopy or sputum culture) ie [12], but there is a paucity of information relating to differ-
ences in the host immune profiles depending on the severity of active disease (or bacterial
load). Most studies find no or weak correlation of peripheral blood Mtb responses to mycobac-
terial load determined using smear or GeneXpert [13]. Indeed, in our study, when analysing
antigen-stimulated whole blood, the only significant correlation (albeit relatively weak) was
seen with the level of RANTES following PPD-stimulation with no differences seen following
EC stimulation or in the unstimulated samples. However, in sputum we found 20/27 analytes
showed significant positive correlation between bacterial and host levels in the same sputum
sample. Of the cytokines we found significant correlations with, we have previously shown
that IL-1β, IL-4, IL-7, IL-8, IL-13, IL-17, G-CSF, MCP-1 and TNFα are present in higher con-
centrations in ex vivo sputum than in serum or Mtb-stimulated blood [10]. This suggests that
Fig 3. Correlation of MBL and host cytokines in blood and sputum. Bacterial load was analysed for each
sputum sample and correlated with host biomarkers (pg/ml) in the same sputum sample and also in Mtb-
stimulated and unstimulated blood using a 27-plex cytokine assay. R-values >0.4 are highlighted in yellow
and significant p-values in purple. Data were analysed using a Spearman Rank Correlation. Correlation of
Time-on treatment with host biomarkers in sputum was also performed.
doi:10.1371/journal.pone.0168272.g003
Host Correlates of Bacterial Load in TB
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Fig 4. Heatmap of cytokine profiles in patients with low and high bacterial loads. Cytokine levels (pg/ml) for
unstimulated (NIL) and sputum supernatants were analysed using a 27-plex cytokine array. Subjects were grouped
into those with low bacterial load (below the median of 48059 copies/ml) and high bacterial load (above median).
Data were analysed using a Mann-Whitney U-test. NS = not significant. Colour indicates low (blue) to high (red)
cytokine levels.
doi:10.1371/journal.pone.0168272.g004
Host Correlates of Bacterial Load in TB
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there are more pronounced changes in the immune response in the lungs during Mtb infec-
tion, which are more readily and accurately measured in sputum samples from the site of
infection, rather than monitoring the concentrations of cytokines in the blood.
When we analysed samples based on high and low bacterial load, there were no significant
differences in the cytokine values of whole blood stimulated with EC or PPD. However, there
was a significant shift of the immune profile in unstimulated blood, with 17 of the 27 cytokines
analysed (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-9, IL-13, IL-17, Eotaxin, IFN-γ, IP-10, MCP-1, MIP-
1α, MIP-1β, PDGF, RANTES, VEGF) being significantly lower in patients with higher bacte-
rial load and levels of IL10, IL15 and TNF-α being higher. Unstimulated blood levels of IFN-γ
have been found to be lower in active compared to latently infected people, whereas IL-4, IP-
10, and VEGF have all been higher [13]. TNF-α has also been shown to be protective in latently
infected subjects but associated with lung pathology and cavitary disease in subjects with
higher levels in active TB disease [14]. Many of the cytokine levels that decreased in unstimu-
lated blood increased in the sputum, possibly due to sequestration of activated cells to the site
of infection as shown previously by our group [15]. The most significant increases were in IL-
1β, IL-2, IL-8, IL-17, FGF, IFN-γ, MIP-1α, MIP-1β, TNF-α and VEGF. These factors all con-
tribute to prolonged inflammation and tissue damage during disease. Following multiple logis-
tic regression adjusting for time on therapy, age, sex, HIV status, smear grade and CXR score,
we found a significant correlation between bacterial load and levels of IL1β, IL2, IL4, IL8, IL17,
Eotaxin, FGF, IFN-γ, MIP1α, MIP1β, PDGF and TNFα.
In conclusion, we have demonstrated the clinical utility of the MBL assay for diagnosis and
treatment response in pulmonary TB patients. Our data highlight the importance of analysing
samples from the site of infection and provide novel correlates of bacterial load that could be
developed further as a point-of-care assay following validation in different subject groups. Our
findings have implications for patient management at diagnosis and treatment response
monitoring.
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